TrialJournal of atherosclerosis and thrombosis2019

Efficacy and Safety of Alirocumab in Japanese Patients with Diabetes Mellitus: Post-hoc Subanalysis of ODYSSEY Japan.

Tamio Teramoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.